Overall, patients with severe COVID-19 present with lymphopenia [14,29], and are likely to have increased inflammatory cytokines such as IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF), and granulocyte colony-stimulating factor (G-CSF) [7,17,30]. This evidence concerns the gene CSF2 and COVID-19.